Study of Naltrexone for Methamphetamine Addiction

NCT00984360 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Methamphetamine Dependence

Interventions

DRUG: Naltrexone

Sponsor

California Pacific Medical Center Research Institute